Detalhe da pesquisa
1.
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
Br J Cancer
; 130(5): 808-818, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225422
2.
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Lancet Oncol
; 24(6): 611-623, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269842
3.
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Lancet Oncol
; 22(5): 727-736, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33862002
4.
Predictive classifier for intensive treatment of head and neck cancer.
Cancer
; 126(24): 5263-5273, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33017867
5.
Incorporating absolute effects to enrich interpretation of findings from meta-analyses - Authors' reply.
Lancet Oncol
; 24(9): e359, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657474
6.
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
BMC Cancer
; 18(1): 787, 2018 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30081865
7.
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
Lancet Oncol
; 18(9): 1221-1237, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28757375
8.
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.
N Engl J Med
; 368(12): 1101-10, 2013 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23514287
9.
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial.
Biometrics
; 72(3): 907-16, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26890381
10.
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
BMC Med Res Methodol
; 16: 37, 2016 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025706
11.
Postoperative radiotherapy for non-small cell lung cancer.
Cochrane Database Syst Rev
; 10: CD002142, 2016 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27727451
12.
Postoperative radiotherapy for non-small cell lung cancer.
Cochrane Database Syst Rev
; 9: CD002142, 2016 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27684386
13.
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
Lancet Oncol
; 16(6): 645-55, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25957714
14.
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival.
J Neurooncol
; 123(2): 307-14, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975195
15.
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Cochrane Database Syst Rev
; (3): CD011430, 2015 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25730344
16.
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Lancet Oncol
; 15(8): 819-28, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852116
17.
Are Individual patient data meta-analyses still needed today in oncology? A discussion focused on Head and Neck oncology.
Acta Oncol
; 58(10): 1333-1336, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31478777
18.
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.
Lancet Oncol
; 14(7): 619-26, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23680111
19.
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
Radiother Oncol
; 190: 110011, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956890
20.
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.
Radiother Oncol
; 197: 110329, 2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768714